The FDA met on June 10 regarding the approval of Ginlenia, the first oral pill for MS. The advisory board voted 25-0 to recommend approval. The FDA usually follows this board's advice when giving the final green light. They have postponed sale of it for 3 more months until September to think about safety measures since the drug is a new entity. It looks like we may have these pills by fall.
These articles have very useful information.
http://m.industry.bnet.com/pharma/10...-drug-gilenia/
http://cenblog.org/the-haystack/2010...e-green-light/
http://www.webmd.com/multiple-sclero...t-oral-ms-drug